Почетна › Рак (све врсте) › Kalifornija › Irvine
Kliničke studije za Рак (све врсте) u gradu Irvine, CA
18 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Irvine i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Тражи се учесникФаза 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Kaiser Permanente-Irvine, Irvine
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Тражи се учесникФаза 2
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Тражи се учесникФаза 3
- University of California, Irvine, Irvine
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 3
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Тражи се учесникФаза 1
- University of California Irvine, Irvine
- Lennar Foundation Cancer Center, Irvine
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Тражи се учесникФаза 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Тражи се учесникФаза 1/2
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Тражи се учесникФаза 2/3
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Тражи се учесникФаза 2/3
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 284734, Irvine
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Тражи се учесникФаза 2/3
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 3
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
Statins to Prevent Cancer Associated Blood Clots
Тражи се учесникФаза 4
- City of Hope, Irvine
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Тражи се учесникФаза 3
- Hoag Hospital Center, Irvine
- Hoag Hospital Irvine, Irvine
Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
Тражи се учесник
- UCI Health Susan Samueli Integrative Health Institute, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Irvine
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Тражи се учесникФаза 1
- UC Irvine, Irvine
A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
Тражи се учесник
- University of California, Irvine, Irvine
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Тражи се учесник
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Studije za Рак (све врсте) u drugim gradovima
- Houston, TX124 студија
- New York City, NY105 студија
- Boston, MA90 студија
- Los Angeles, CA73 студија
- Nashville, TN65 студија
- Durham, NC61 студија
- Washington, DC60 студија
- Philadelphia, PA57 студија
- Arlington, VA52 студија
- Chicago, IL51 студија
- St. Louis, MO51 студија
- Atlanta, GA49 студија
Ostale studije u gradu Irvine
- Немалоклетни карцином плућа30 студија
- Рак дојке23 студија
- Метастатски карцином16 студија
- Рак плућа15 студија
- Рак јајника14 студија
- Рак простате14 студија
- Многи мијелом14 студија
- Алцхајмерова болест12 студија
- Плоскоклеточни карцином главе и врата11 студија
- Рак бешике11 студија
- Колоректални карцином11 студија
- Карцином ендометријума10 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.